[Case Study] Koji Masuda and Kenji Ikeda “TDM Is Not Only for Safety, but for Ensuring Effectiveness” (AMR Alliance Japan, March 31, 2022)
date : 3/31/2022
Tags: AMR
As part of a project to promote antimicrobial steward among medical professionals, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has been publishing case studies from various experts related to antimicrobial resistance.
The latest case report was created by Dr. Koji Masuda (Vice Chief Pharmacist, Department of Pharmacy, International Healthcare and welfare University, NARITA Hospital) and Dr. Kenji Ikeda (Chief Pharmacist, International Healthcare and welfare University, NARITA Hospital / Deputy Director, Department of Pharmacy, Narita Hospital, International University of Health and Welfare). It is entitled, “TDM Is Not Only for Safety, but for Ensuring Effectiveness.”
This is the third of three case studies from AMR Alliance Japan on the usefulness of TDM for antimicrobial stewardship.
Case study 08
Dr. Koji Masuda (Vice Chief Pharmacist, Department of Pharmacy, International Healthcare and welfare University, NARITA Hospital)
Dr. Kenji Ikeda (Chief Pharmacist, International Healthcare and welfare University, NARITA Hospital / Deputy Director, Department of Pharmacy, Narita Hospital, International University of Health and Welfare)
“TDM Is Not Only for Safety, but for Ensuring Effectiveness.”
For further information, please see the case study below.
■ Case studies from various experts related to AMR
Case study 07 – Patient’s Voice
Ms. Sachiko Ito (Supporter, AMR Alliance Japan / Person Affected by Non-tuberculous Mycobacterial (NTM) Lung Disease)
“I hope more healthcare professionals take an interest in Antimicrobial Resistance (AMR) and work to promote the appropriate usage of antimicrobials.”
Top Research & Recommendations Posts
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Discussion Points] Obesity Control as a Challenge for Society: Promoting Understanding of Obesity and Finding Solutions Through Multi-Stakeholder Collaboration (August 21, 2025)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
-
2026-02-05
[Registration Open] (Webinar) The 141st HGPI Seminar “Current Status and Future Prospects of Korea’s Obesity Policy: Voices of People with Lived Experience in Policy Promotion” (March 3, 2026)
-
2026-02-06
[Research Report] AMR Policy Update #5: Cancer Care and AMR (Part 2)



